Executive Summary
Two bullish HHS contracts totaling $414.7M obligated (potential $670.6M with options) signal multi-year revenue stability for health services providers via cost-plus structures minimizing risk. Wisconsin Physicians Service dominates with $319M CMS Medicare admin award, while Charles River adds $96M NIH preclinical support, highlighting HHS outsourcing trends. Unexercised options offer $252M upside amid extensions to 2028-2029.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior All HHS Contracts digest from March 14, 2026.
Investment Signals (2)
- HHS cost-plus awards lock in low-risk revenue (HIGH)▲
Both contracts use cost-plus pricing with $414.7M obligated and outlays of $241M, providing visibility through 2026+ amid full competition wins.
- Medicare admin and preclinical services expansion (HIGH)▲
CMS $319M award to nonprofit insurer and NIH $96M to lab firm underscore demand for outsourced admin and research support services.
Risk Flags (2)
- Execution [MEDIUM RISK]▼
Performance fees and unexercised options ($252M total) could limit full value capture if milestones missed.
- Regulatory [MEDIUM RISK]▼
Budget shifts or non-extension beyond 2026-2027 could truncate periods to 2028-2029 potentials.
Opportunities (2)
- ◆
$252M unexercised options across contracts offer near-term revenue expansion.
- ◆
HHS extensions to 2028-2029 signal multi-year backlog growth in admin and lab services.
Sector Themes (2)
- ◆
Both awards use low-risk pricing for Medicare admin (NAICS 524114) and facilities support (NAICS 561210), with 80%+ unexercised option value.
- ◆
Dominant $319M CMS award vs. $96M NIH shows Medicare admin scale exceeding research support.
Watch List (2)
- 👁
{"entity"=>"Wisconsin Physicians Service Insurance Corp.", "reason"=>"$319M obligation (66% of period total) with $167M options; nonprofit stability via CMS.", "trigger"=>"Option exercises or 2026 extension to 2028"}
- 👁
{"entity"=>"Charles River Laboratories, Inc.", "reason"=>"$96M NIH award with $89M options and 43% outlay progress signals preclinical momentum.", "trigger"=>"Full option exercise or 2027 extension to 2029"}
Get daily alerts with 2 investment signals, 2 risk alerts, 2 opportunities and full AI analysis of all 2 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: All HHS Contracts
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals